VolitionRX Ltd. (VNRX)
0.3323
-0.02
(-4.95%)
USD |
NYAM |
Sep 08, 16:00
0.3296
0.00 (0.00%)
Pre-Market: 09:08
VolitionRX Enterprise Value : 11.25M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 11.25M |
| September 04, 2026 | 11.46M |
| September 03, 2026 | 11.46M |
| September 02, 2026 | 11.78M |
| September 01, 2026 | 11.99M |
| August 31, 2026 | 12.47M |
| August 28, 2026 | 12.66M |
| August 27, 2026 | 13.28M |
| August 26, 2026 | 11.33M |
| August 25, 2026 | 11.88M |
| August 24, 2026 | 11.95M |
| August 21, 2026 | 12.27M |
| August 20, 2026 | 12.60M |
| August 19, 2026 | 13.12M |
| August 18, 2026 | 12.96M |
| August 17, 2026 | 13.27M |
| August 14, 2026 | 13.72M |
| August 13, 2026 | 14.84M |
| August 12, 2026 | 15.30M |
| August 11, 2026 | 15.86M |
| August 10, 2026 | 16.48M |
| August 07, 2026 | 16.58M |
| August 06, 2026 | 16.47M |
| August 05, 2026 | 16.82M |
| August 04, 2026 | 16.70M |
| Date | Value |
|---|---|
| August 03, 2026 | 16.88M |
| July 31, 2026 | 15.89M |
| July 30, 2026 | 16.88M |
| July 29, 2026 | 16.55M |
| July 28, 2026 | 17.50M |
| July 27, 2026 | 17.84M |
| July 24, 2026 | 19.29M |
| July 23, 2026 | 20.25M |
| July 22, 2026 | 19.77M |
| July 21, 2026 | 20.61M |
| July 20, 2026 | 20.86M |
| July 17, 2026 | 20.49M |
| July 16, 2026 | 21.22M |
| July 15, 2026 | 21.46M |
| July 14, 2026 | 22.54M |
| July 13, 2026 | 22.90M |
| July 10, 2026 | 23.50M |
| July 09, 2026 | 23.38M |
| July 08, 2026 | 23.44M |
| July 07, 2026 | 24.11M |
| July 06, 2026 | 23.50M |
| July 02, 2026 | 24.11M |
| July 01, 2026 | 23.63M |
| June 30, 2026 | 23.50M |
| June 29, 2026 | 18.48M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 210.25B |
| Align Technology, Inc. | 9.954B |
| AngioDynamics, Inc. | 591.77M |
| Accuray, Inc. | 177.77M |
| Alphatec Holdings, Inc. | 1.912B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.775M |
| Revenue (Quarterly) | 0.3987M |
| Total Expenses (Quarterly) | 8.185M |
| EPS Diluted (Quarterly) | -0.8505 |
| Gross Profit Margin (Quarterly) | 28.37% |
| Profit Margin (Quarterly) | -1.95K% |
| Earnings Yield | -1.16K% |
| Normalized Earnings Yield | -1078.09 |